Lin Yang1, Rennan Feng, Guiyou Liu, Mingzhi Liao, Liangcai Zhang, Wenbo Wang. 1. Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, 23 Youzheng St., Nangang District, Harbin 150001, People's Republic of China.
Abstract
OBJECTIVE: Tumor necrosis factor-β (TNF-β) plays important roles in mediating cancer development. Many studies have argued possible associations of TNF-β +252 A>G polymorphism with different cancers. However, association between this most frequently studied polymorphism and susceptibility to cancer still remains controversial and ambiguous. The aim of this study is to determine the relationship of TNF-β +252 A>G polymorphism with cancer through meta-analysis. METHODS: Electronic searches of several databases were conducted for all publications on the associations between this variant and cancer through October 2011. Odds ratios (ORs) with 95 % confidence intervals (95 % CIs) were used to access the strength of this association in random-effect model. RESULTS: Thirty-three studies with 14,435 cancer patients and 10,583 healthy controls were included. In this meta-analysis, we detected statistically significant connections between this polymorphism and cancer risks [GG + GA vs. AA: OR = 1.24, 95 % CI = 1.02-1.51; GG vs. AA: OR = 1.43, 95 % CI = 1.05-1.95; G vs. A: OR = 1.28, 95 % CI = 1.28 (1.09-1.50)] in the overall ethnic population. Meanwhile, we detected significant associations in Asian population (GG + GA vs. AA), other population (GG vs. GA + AA), and Caucasian population (GG vs. AA, G vs. A) with the OR values being 1.21 (1.04-1.40), 1.64 (1.35-1.99), 1.65 (1.02, 2.65), and 1.39 (1.09-1.75), respectively. CONCLUSIONS: TNF-β +252 A>G polymorphism is positively associated with susceptibility to cancer. However, this study also suggests that more studies should be conducted to further confirm the associations between this variant and specific types of cancers.
OBJECTIVE: Tumor necrosis factor-β (TNF-β) plays important roles in mediating cancer development. Many studies have argued possible associations of TNF-β +252 A>G polymorphism with different cancers. However, association between this most frequently studied polymorphism and susceptibility to cancer still remains controversial and ambiguous. The aim of this study is to determine the relationship of TNF-β +252 A>G polymorphism with cancer through meta-analysis. METHODS: Electronic searches of several databases were conducted for all publications on the associations between this variant and cancer through October 2011. Odds ratios (ORs) with 95 % confidence intervals (95 % CIs) were used to access the strength of this association in random-effect model. RESULTS: Thirty-three studies with 14,435 cancerpatients and 10,583 healthy controls were included. In this meta-analysis, we detected statistically significant connections between this polymorphism and cancer risks [GG + GA vs. AA: OR = 1.24, 95 % CI = 1.02-1.51; GG vs. AA: OR = 1.43, 95 % CI = 1.05-1.95; G vs. A: OR = 1.28, 95 % CI = 1.28 (1.09-1.50)] in the overall ethnic population. Meanwhile, we detected significant associations in Asian population (GG + GA vs. AA), other population (GG vs. GA + AA), and Caucasian population (GG vs. AA, G vs. A) with the OR values being 1.21 (1.04-1.40), 1.64 (1.35-1.99), 1.65 (1.02, 2.65), and 1.39 (1.09-1.75), respectively. CONCLUSIONS: TNF-β +252 A>G polymorphism is positively associated with susceptibility to cancer. However, this study also suggests that more studies should be conducted to further confirm the associations between this variant and specific types of cancers.
Authors: T Onishi; Y Ohishi; H Goto; K Asano; H Makino; T Hatano; M Tomita; K Abe; K Imagawa; M Kinoshita; T Fukui Journal: Nihon Hinyokika Gakkai Zasshi Date: 1998-03
Authors: J B A Crusius; F Canzian; G Capellá; A S Peña; G Pera; N Sala; A Agudo; F Rico; G Del Giudice; D Palli; M Plebani; H Boeing; H B Bueno-de-Mesquita; F Carneiro; V Pala; V E Save; P Vineis; R Tumino; S Panico; G Berglund; J Manjer; R Stenling; G Hallmans; C Martínez; M Dorronsoro; A Barricarte; C Navarro; J R Quirós; N Allen; T J Key; S Binghan; C Caldas; J Linseisen; R Kaaks; K Overvad; A Tjønneland; F C Büchner; P H M Peeters; M E Numans; F Clavel-Chapelon; A Trichopoulou; E Lund; M Jenab; S Rinaldi; P Ferrari; E Riboli; C A González Journal: Ann Oncol Date: 2008-07-14 Impact factor: 32.976
Authors: Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland Journal: PLoS One Date: 2010-07-27 Impact factor: 3.240
Authors: João Paulo C de Oliveira; Flora Fernandes; Angela K Cruz; Viviane Trombela; Elisângela Monteiro; Anamaria A Camargo; Aldina Barral; Camila I de Oliveira Journal: Kinetoplastid Biol Dis Date: 2007-06-21